194 related articles for article (PubMed ID: 10878487)
21. Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris.
Veldman C; Höhne A; Dieckmann D; Schuler G; Hertl M
J Immunol; 2004 May; 172(10):6468-75. PubMed ID: 15128839
[TBL] [Abstract][Full Text] [Related]
22. Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice.
Takahashi H; Kouno M; Nagao K; Wada N; Hata T; Nishimoto S; Iwakura Y; Yoshimura A; Yamada T; Kuwana M; Fujii H; Koyasu S; Amagai M
J Clin Invest; 2011 Sep; 121(9):3677-88. PubMed ID: 21821914
[TBL] [Abstract][Full Text] [Related]
23. T cell receptor gene usage in desmoglein-3-specific T lymphocytes from patients with pemphigus vulgaris.
Hacker-Foegen MK; Fairley JA; Lin MS
J Invest Dermatol; 2003 Dec; 121(6):1365-72. PubMed ID: 14675184
[TBL] [Abstract][Full Text] [Related]
24. Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance.
Ota T; Aoki-Ota M; Tsunoda K; Nishikawa T; Koyasu S; Amagai M
Int Immunol; 2008 Oct; 20(10):1351-60. PubMed ID: 18765425
[TBL] [Abstract][Full Text] [Related]
25. Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models.
Ujiie H; Shimizu H
Exp Dermatol; 2012 Dec; 21(12):901-5. PubMed ID: 23016514
[TBL] [Abstract][Full Text] [Related]
26. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris.
Takahashi H; Amagai M; Nishikawa T; Fujii Y; Kawakami Y; Kuwana M
J Immunol; 2008 Jul; 181(2):1526-35. PubMed ID: 18606708
[TBL] [Abstract][Full Text] [Related]
27. HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy.
Riechers R; Grötzinger J; Hertl M
Autoimmunity; 1999; 30(3):183-96. PubMed ID: 10520901
[TBL] [Abstract][Full Text] [Related]
28. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
[TBL] [Abstract][Full Text] [Related]
29. Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris.
Rico MJ; Benning C; Weingart ES; Streilein RD; Hall RP
Br J Dermatol; 1999 Jun; 140(6):1079-86. PubMed ID: 10354074
[TBL] [Abstract][Full Text] [Related]
30. Pemphigus--paradigm of autoantibody-mediated autoimmunity.
Hertl M; Veldman C
Skin Pharmacol Appl Skin Physiol; 2001; 14(6):408-18. PubMed ID: 11598441
[TBL] [Abstract][Full Text] [Related]
31. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease.
Rizzo C; Fotino M; Zhang Y; Chow S; Spizuoco A; Sinha AA
Clin Exp Dermatol; 2005 Sep; 30(5):535-40. PubMed ID: 16045688
[TBL] [Abstract][Full Text] [Related]
32. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
[TBL] [Abstract][Full Text] [Related]
33. Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3.
Veldman C; Pahl A; Hertl M
Immunology; 2009 May; 127(1):40-9. PubMed ID: 18800988
[TBL] [Abstract][Full Text] [Related]
34. New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria.
Blank M; Gisondi P; Mimouni D; Peserico A; Piaserico S; Shoenfeld Y; Reunala T; Zambruno G; Di Zenzo G; Girolomoni G
Clin Exp Rheumatol; 2006; 24(1 Suppl 40):S20-5. PubMed ID: 16466621
[TBL] [Abstract][Full Text] [Related]
35. Autoreactive T cell responses in pemphigus and pemphigoid.
Oostingh GJ; Sitaru C; Kromminga A; Dormann D; Zillikens D
Autoimmun Rev; 2002 Oct; 1(5):267-72. PubMed ID: 12848979
[TBL] [Abstract][Full Text] [Related]
36. Searching for foreign antigens as possible triggering factors of autoimmunity: Torque Teno virus DNA prevalence is elevated in sera of patients with bullous pemphigoid.
Blazsek A; Sillo P; Ishii N; Gergely P; Poor G; Preisz K; Hashimoto T; Medvecz M; Kárpáti S
Exp Dermatol; 2008 May; 17(5):446-54. PubMed ID: 18400063
[TBL] [Abstract][Full Text] [Related]
37. Epidermal adhesion molecules and basement membrane components as target structures of autoimmunity.
Moll R; Moll I
Virchows Arch; 1998 Jun; 432(6):487-504. PubMed ID: 9672190
[TBL] [Abstract][Full Text] [Related]
38. Immune complexes in pemphigus and bullous pemphigoid.
Ahmed AR; Moy RL; Chia D; Barnett EV
Dermatologica; 1983; 166(4):175-80. PubMed ID: 6343146
[TBL] [Abstract][Full Text] [Related]
39. Cytokine networks in Pemphigus vulgaris: An integrated viewpoint.
Giordano CN; Sinha AA
Autoimmunity; 2012 Sep; 45(6):427-39. PubMed ID: 22686612
[TBL] [Abstract][Full Text] [Related]
40. Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases.
Li N; Zhao M; Hilario-Vargas J; Prisayanh P; Warren S; Diaz LA; Roopenian DC; Liu Z
J Clin Invest; 2005 Dec; 115(12):3440-50. PubMed ID: 16284651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
